Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2019 | 2018 | 2014
Number of items: 4.

2022

Eichler, Christian, Uener, Jens, Thangarajah, Fabinshy, Radosa, Julia, Zinser, Max, Fischer, Lotta Ada, Puppe, Julian, Warm, Matthias, Malter, Wolfram and Lenz, Caroline ORCID: 0000-0001-7001-1969 (2022). Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients. Arch. Gynecol. Obstet., 306 (4). S. 1171 - 1177. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-0711

2019

Thangarajah, Fabinshy, Eichler, Christian, Fromme, Julia, Malter, Wolfram, Radosa, Julia Caroline, Ludwig, Sebastian, Puppe, Julian, Paepke, Stefan and Warm, Matthias (2019). The impact of EndoPredict((R))on decision making with increasing oncological work experience: can overtreatment be avoided? Arch. Gynecol. Obstet., 299 (5). S. 1437 - 1443. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-0711

2018

Gluz, Oleg, Liedtke, Cornelia, Prat, Aleix, Christgen, Matthias, Gebauer, Daniel, Kates, Ronald, Pelz, Enrico, Clemens, Michael, Warm, Matthias, Aktas, Bahriye, Kuemmel, Sherko, Pare, Laia, Krabisch, Petra, Kreipe, Hans Heinrich, Wuerstlein, Rachel, Nitz, Ulrike and Harbeck, Nadia (2018). Genomic markers but not molecular subtypes provide prognostic impact and predict anthracycline efficacy in early triple-negative breast cancer: Results from the prospective WSG PlanB trial. Cancer Res., 78 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

2014

Fasching, Peter A., Jud, Sebastian M., Hauschild, Maik, Kuemmel, Sherko, Schuette, Martin, Warm, Matthias, Hanf, Volker, Grab, Dieter, Krocker, Jutta, Stickeler, Elmar, Kreienberg, Rolf, Mueller, Thomas, Kuehn, Thorsten, Wolf, Christopher, Kahlert, Steffen, Paepke, Stefan, Berghorn, Michael, Muth, Mathias, Baier, Monika, Wackwitz, Birgit, Schulz-Wendtland, Ruediger, Beckmann, Matthias W. and Lux, Michael P. (2014). FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients. BMC Cancer, 14. LONDON: BMC. ISSN 1471-2407

This list was generated on Thu Apr 18 02:30:53 2024 CEST.